Sun, Mar 18, 2018
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Industry Updates

Amber Capital launches UCITS version of Italia Equity fund with $80m on Alpha UCITS Platform

Wednesday, October 02, 2013
Opalesque Industry Update - The Alpha UCITS Platform has launched today the Amber Equity Fund. The Amber Equity Fund is managed by Amber Capital Italia SGR, a Milan based asset management company regulated by the Bank of Italy and established by Joseph Oughourlian, founder of the Amber Capital Group, the successful investment firm founded in 2001 with main offices in London and New York.

Amber Capital Italia has decided to transform its almost four-year old Italian domestic fund, Amber Italia Equity, into a UCITS fund called Amber Equity Fund. The Amber Italia Equity fund, incorporated in Italy as an approved domestic fund, was already managed by Giorgio Martorelli, portfolio manager of Amber Capital Italia, according to rules very similar to those of a UCITS fund.

The Amber Italia Equity fund’s cumulative performance since inception in November 2009 has been +21.94%, compared to a FTSE MIB Index performance over the same period of -26.13% (as of 31 August 2013), with a worst month of -2.47%, a volatility below 5% and a net exposure to equity markets close to zero. The fund is up +10.41% YTD as of 31 August 2013.

Most existing investors in the Amber Italia Equity fund, all Italian institutional investors and management of the Amber Group, have subscribed to the new Luxembourg UCITS Amber Equity Fund. Consequently, the UCITS fund should have about $80m AUM at the end of its ramp-up period.

The Amber Equity Fund aims at returning consistent absolute returns by investing on a long/short basis primarily in European equities, with a focus on Italian investments. The Fund is using a fundamental value and bottom-up approach. The investment strategies employed may encompass, among other things, any or all of the following strategies: directional long or short positions with or without a catalyst; long/short equity pairs with or without a catalyst; capital structure arbitrage; risk arbitrage; share class arbitrage; company holding discounts; and relative- and fundamental-value.

Amber believes that launching a UCITS fund will provide the opportunity to raise further assets, not just in Italy but in Europe and in the rest of the world as well. The target remains professional institutional investors. Amber Capital Italia SGR will be the distributor for the fund and intends to file with CONSOB (through the CSSF) the notification to offer the shares of the fund in Italy and eventually to passport it in other European countries. The aim is to grow the fund from about $80m to $150m in the following six months and to $ 250m in the following 18/24 months.

Joseph Oughourlian said: “I am very proud of the launch of the Amber Equity Fund as it further strengthens our commitment to Italy, a country in which we strongly believe and where we have been present for many years. We are also confident that transforming the Amber Italia Equity fund into a UCITS fund will widen our investor base.”

Giorgio Martorelli said: “The new fund will pursue the same strategy which has generated consistent returns for its investors with low volatility and very limited exposure to the equity markets.”

Alpha UCITS Ltd. is a London based company founded in 2009 by Stephane Diederich, formerly a Partner at Brevan Howard Asset Management LLP. Alpha UCITS is a specialised structuring and distribution platform for UCITS funds launched by blue chip hedge fund managers.

Stephane Diederich commented: “Amber Capital organised a very thorough due diligence on most established UCITS platforms in order to launch its first UCITS fund and we are very excited that Amber Capital has chosen Alpha UCITS as its partner. The Amber Equity Fund is quite unique and will expand the current UCITS product offering. “For more information:

Press release


What do you think?

   Use "anonymous" as my name    |   Alert me via email on new comments   |   
Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Performance - Hedge fund mojo is back with investor hopes at six-year high, These hedge funds produce the most consistently great results[more]

    Hedge fund mojo is back with investor hopes at six-year high From Hedge funds on the heels of a surprisingly strong performance in 2017 are raising hopes for an encore. Investors expect their managers to return 8.5 percent in 2018, according to a Credit Suisse Group AG sur

  2. Investing - Hedge funds amass big bets against world's leading advertisers, Investor Elliott Management buys tiny stake in Wipro[more]

    Hedge funds amass big bets against world's leading advertisers From Hedge funds have amassed bearish bets of more than $3bn against the world's largest advertising companies in an attempt to profit as the industry undergoes ongoing wrenching disruption and slowing growth. Funds i

  3. News Briefs - Investcorp to launch a $100 million PE fund for Omani pension funds[more]

    Bahrain-based investment firm Investcorp will soon launch a $100 million fund dedicated to Oman's Pension Funds as part of its investment plan. 'The Opportunities Fund' will be focused on private equity investments in the U.S. and Europe and will target mid-sized companies across a broad range of se

  4. DoubleLine's Gundlach sees U.S. 10-year Treasury yield rising, weighing on stocks[more]

    From Reuters/ Jeffrey Gundlach, the chief executive of DoubleLine Capital and known on Wall Street as the "Bond King," said on Tuesday the yield on the U.S. 10-year Treasury note will likely move higher and pressure riskier assets including equities and junk bonds. Gundlach, on an

  5. SEC charges Theranos CEO Holmes with fraud[more]

    Bailey McCann, Opalesque New York: The SEC has charged Elizabeth Holmes, founder and CEO of Theranos and its former President Ramesh "Sunny" Balwani with raising more than $700 million from investors through an elaborate, years-long fraud in which they exaggerated or made false statements about t